Cortes-Ballinas L, Lopez-Perez T, Rocha-Zavaleta L
Biomed Rep. 2024; 21(6):175.
PMID: 39355529
PMC: 11443488.
DOI: 10.3892/br.2024.1863.
Wang X, Li Q, Tang Y, Li Y, Zhang L, Xu F
Acta Pharmacol Sin. 2024; 45(12):2625-2645.
PMID: 38942954
PMC: 11579023.
DOI: 10.1038/s41401-024-01310-y.
Q B Alenzi F
Saudi J Biol Sci. 2024; 31(7):104021.
PMID: 38831893
PMC: 11145386.
DOI: 10.1016/j.sjbs.2024.104021.
Zhang W, Sha Z, Tang Y, Jin C, Gao W, Chen C
Adv Sci (Weinh). 2024; 11(22):e2400446.
PMID: 38639386
PMC: 11165510.
DOI: 10.1002/advs.202400446.
Pachimatla A, Fenstermaker R, Ciesielski M, Yendamuri S
Transl Lung Cancer Res. 2024; 13(2):362-374.
PMID: 38496694
PMC: 10938099.
DOI: 10.21037/tlcr-23-621.
A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin.
Song S, Woo J, Kim H, Lee J, Lim W, Moon B
Front Cardiovasc Med. 2024; 11:1324203.
PMID: 38385137
PMC: 10879594.
DOI: 10.3389/fcvm.2024.1324203.
Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.
Cui Q, Huang C, Liu J, Zhang J
J Med Chem. 2023; 66(24):16515-16545.
PMID: 38092421
PMC: 11588358.
DOI: 10.1021/acs.jmedchem.3c01130.
microRNAs Regulate Survivin in Colorectal Cancer Patients.
Chavoshi H, Bornehdeli S, Asadi M, Dolatkhah R, Caner A, Raeisi M
Adv Biomed Res. 2023; 12:227.
PMID: 38073748
PMC: 10699232.
DOI: 10.4103/abr.abr_233_22.
Survivin Small Molecules Inhibitors: Recent Advances and Challenges.
Albadari N, Li W
Molecules. 2023; 28(3).
PMID: 36771042
PMC: 9919791.
DOI: 10.3390/molecules28031376.
RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R.
Badrani J, Strohm A, Lacasa L, Civello B, Cavagnero K, Haung Y
Nat Commun. 2022; 13(1):4435.
PMID: 35908044
PMC: 9338970.
DOI: 10.1038/s41467-022-32176-5.
Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis.
Krieg S, Roderburg C, Fung S, Luedde T, Knoefel W, Krieg A
J Cancer Res Clin Oncol. 2022; 148(9):2235-2246.
PMID: 35428913
PMC: 9349075.
DOI: 10.1007/s00432-022-04013-1.
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.
Shomali N, Maashi M, Baradaran B, Daei Sorkhabi A, Sarkesh A, Mohammadi H
Front Immunol. 2022; 13:839945.
PMID: 35309327
PMC: 8927965.
DOI: 10.3389/fimmu.2022.839945.
The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab.
Chang Z, Dang T, Meng X, Chai J
Cancer Control. 2022; 29:10732748221074734.
PMID: 35291889
PMC: 8935545.
DOI: 10.1177/10732748221074734.
Helicobacter pylori-induced reactive oxygen species direct turnover of CSN-associated STAMBPL1 and augment apoptotic cell death.
Chaithongyot S, Naumann M
Cell Mol Life Sci. 2022; 79(2):86.
PMID: 35066747
PMC: 8784504.
DOI: 10.1007/s00018-022-04135-2.
Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of Glioblastoma.
Nascimento R, Dos Santos B, Amparo J, Soares J, da Silva K, Santana M
Pharmaceutics. 2022; 14(1).
PMID: 35057010
PMC: 8778519.
DOI: 10.3390/pharmaceutics14010116.
Single-cell RNA sequencing reveals differential cell cycle activity in key cell populations during nephrogenesis.
Bais A, Cerqueira D, Clugston A, Bodnar A, Ho J, Kostka D
Sci Rep. 2021; 11(1):22434.
PMID: 34789782
PMC: 8599654.
DOI: 10.1038/s41598-021-01790-6.
Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.
Avrutsky M, Troy C
Front Pharmacol. 2021; 12:701301.
PMID: 34305609
PMC: 8299054.
DOI: 10.3389/fphar.2021.701301.
Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway.
Lee J, Chung J, Byun Y, Kim K, An S, Kwon K
Int J Mol Sci. 2021; 22(13).
PMID: 34281156
PMC: 8267634.
DOI: 10.3390/ijms22137102.
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells.
Zangouei A, Moghbeli M
Genes Environ. 2021; 43(1):21.
PMID: 34099061
PMC: 8182944.
DOI: 10.1186/s41021-021-00192-4.
The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth.
Xu F, Sun H, Fang R, Zhang L, Shi H, Wang X
Acta Pharmacol Sin. 2021; 43(2):429-445.
PMID: 33824459
PMC: 8791967.
DOI: 10.1038/s41401-021-00631-6.